| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |